About the speaker
Prof Emmanuelle Charpentier studied biochemistry, microbiology and genetics at the University Pierre and Marie Curie, Paris, France and obtained her PhD in Microbiology for her research performed at the Pasteur Institute. She then continued her work in the United States, at the Rockefeller University, New York University Langone Medical Center and the Skirball Institute of Biomolecular Medicine and at St Jude Children's Research Hospital. Prof Charpentier returned to Europe to establish her own research group as an Assistant and Associate Professor at the Max F. Perutz Laboratories of the University of Vienna in Austria where she habilitated in the field of Microbiology. She was then appointed Associate Professor at the Laboratory for Molecular Infection Medicine Sweden at Umeå University and is still active as a Visiting Professor. In 2015, Prof Charpentier was appointed Scientific Member of the Max Planck Society in Germany and Director at the Max Planck Institute for Infection Biology in Berlin, Germany.
Prof Charpentier is recognized as a world-leading expert in regulatory mechanisms underlying processes of infection and immunity in bacterial pathogens. Her work has led to a number of seminal discoveries and insights into pathways governing antibiotic resistance and virulence of bacterial pathogens. With her recent groundbreaking findings in the field of RNA-mediated regulation based on the CRISPR-Cas9 system, Prof Charpentier has laid the foundation for the development of a novel, highly versatile and specific genome editing technology that is revolutionizing life sciences research and could open up whole new opportunities in biomedical gene therapies.
Prof Charpentier is Elected Foreign Member of the Royal Swedish Academy of Sciences 2015, Elected Member German National Academy of Sciences 2015, Elected Member of the European Academy of Microbiology 2015, Elected Fellow of the American Academy of Microbiology in 2015 and Elected EMBO Member in 2014. She has been awarded prestigious honors including the 2016 Warren Alpert Foundation Prize, the Paul Ehrlich and Ludwig Darmstaedter Prize 2016, French Chevalier Order de la Légion d’Honneur in 2016, World Technology Award for Biotechnology 2015, Leibniz Prize 2016, the 2016 HFSP Nakasone Award, the Science Award of Lower Saxony 2015, the ABRF Annual Award for Outstanding Contributions to Biomolecular Technologies 2016, the Massry Prize 2015, the L’Oréal-UNESCO For Women in Science Award 2016, the Louis Jeantet Prize for Medicine 2015, the Ernst Jung Prize for Medicine 2015, the Breakthrough Prize in Life Sciences 2015, the Grand Prix Jean-Pierre LeCocq 2014, the Jacob Heskel Gabbay Award in Biotechnology and Medicine 2014, an Alexander von Humboldt Professorship in 2013 and the Eric K. Fernström Prize in 2011. Prof Charpentier was also selected as one of TIME’s 100 Most Influential People in the World in 2015, one of Foreign Policy’s 100 Leading Global Thinkers in 2014 and one of Vanity Fair’s 50 most influential French people worldwide in 2014.
|
